Skip to main content

Direct measurement of atrioventricular valve regurgitant jets using 4D flow cardiovascular magnetic resonance is accurate and reliable for children with congenital heart disease: a retrospective cohort study



3D-time resolved flow (4DF) cardiovascular magnetic resonance (CMR) with retrospective analysis of atrioventricular valve regurgitation (AVVR) allows for internal validation by multiple direct and indirect methods. Limited data exist on direct measurement of AVVR by 4DF CMR in pediatric congenital heart disease (CHD). We aimed to validate direct measurement of the AVVR jet as accurate and reliable compared to the volumetric method (clinical standard by 2D CMR) and as a superior method of internal validation than the annular inflow method.


We identified 44 consecutive patients with diverse CHD referred for evaluation of AVVR by CMR. 1.5 T or 3 T scanners, intravenous contrast, and a combination of parallel imaging and compressed sensing were used. Four methods of measuring AVVR volume (RVol) were used: volumetric method (VOL; the clinical standard) = stroke volume by 2D balanced steady-state free precession – semilunar valve forward flow (SLFF); annular inflow method (AIM) = atrioventricular valve forward flow [AVFF] – semilunar valve net flow (SLNF); and direct measurement (JET). AVFF was measured using static and retrospective valve tracking planes. SLFF, SLNF, AVFF, and JET were measured by 4DF phase contrast. Regurgitant fraction was calculated as [RVol/(RVol+SLNF)]× 100. Statistical methods included Spearman, Wilcoxon rank sum test/Student paired t-test, Bland Altman analysis, and intra-class coefficient (ICC), where appropriate.


Regurgitant fraction by JET strongly correlated with the indirect methods (VOL and AIM) (ρ = 0.73–0.80, p < 0.001) and was similar to VOL with a median difference (interquartile range) of − 1.5% (− 8.3–7.2%; p = 0.624). VOL had weaker correlations with AIM and JET (ρ = 0.69–0.73, p < 0.001). AIM underestimated RF by 3.6–6.9% compared to VOL and JET, p < 0.03. Intra- and inter- observer reliability were excellent for all methods (ICC 0.94–0.99). The mean (±standard deviation) inter-observer difference for VOL was 2.4% (±5.1%), p < 0.05.


In a diverse cohort of pediatric CHD, measurement of AVVR using JET is accurate and reliable to VOL and is a superior method of internal validation compared to AIM. This study supports use of 4DF CMR for measurement of AVVR, obviating need for expert prospective prescription during image acquisition by 2D CMR.


The presence of atrioventricular valve regurgitation (AVVR) causes significant morbidity and mortality in patients with congenital heart disease (CHD) [1,2,3,4,5,6]. AVVR of moderate or greater degrees is a significant risk factor for unwanted outcomes, including re-operation in patients with repaired atrioventricular septal defects and death or heart transplantation in the single ventricle populations [5,6,7]. In CHD, the initial mechanism of AVVR is most likely anatomic abnormalities such as septal clefts, dysplasia, or prolapse. As a result of progressive, eccentric regurgitation, a pathologic cycle develops of volume overload, annular dilation, and worsened regurgitation [5, 8]. Although the standard of care for initial evaluation of AVVR is transthoracic echocardiography, accuracy and reliability is limited in distinguishing moderate from severe regurgitation—a distinction particularly important as it impacts surgical management [9,10,11,12]. Within this context, cardiovascular magnetic resonance (CMR) has become the clinical standard for calculating AVVR, leveraging its strengths as the gold standard for measuring ventricular volumes and flow [9, 13,14,15,16,17].

The recommended method of measuring AVVR by 2D CMR is through the volumetric (VOL) method—the difference between ventricular stroke volume (by planimetry) and forward flow across the respective semilunar valve (assessed by phase contrast imaging (PC) CMR) [9, 13,14,15,16,17,18]. Compared to echocardiography, the VOL method has better reliability [9, 10, 16, 19, 20] and accuracy based on correlation with outcome measures including surgical indication and ventricular remodeling after surgery [9, 20, 21]. However, in patients with complex CHD, the reliance on two separate CMR techniques and measurement errors inherent in planimetry can negatively impact accuracy and reliability [16]. The annular inflow method, calculated as the difference between atrioventricular (AV) forward flow and semilunar net flow (both assessed by PC), has similar reliability as the VOL method and can be internally validated by comparison of net inflow and outflow measurements [15, 22,23,24]. Manual retrospective valve-tracking has improved the accuracy of measuring AV flow by accounting for the basal displacement of the annulus during diastole instead of using a static plane which can overestimate AV flow [23, 25, 26].

In addition to the above two indirect measures of regurgitant flow, direct measurement of the regurgitant jet by a static 2D plane is also possible. This method is limited by dynamic motion of the valve, complex valvular anatomy, number and eccentricity of jets, and change in angulation of the jet during the cardiac cycle [16, 23, 27,28,29]. Recent advancements in 3D phase-contrast CMR (4D flow or 4DF) including compressed sensing, parallel imaging, and motion correction allow for practical solutions to these limitations with short scan times and creation of manually adjustable planes during post-processing. 4DF is a validated and reliable method for the measurement of flow and volume that has become part of standard clinical imaging at some institutions [22,23,24,25,26, 30,31,32,33,34,35,36,37,38,39]. While indirect methods of measuring AVVR have been validated with 4DF CMR [22,23,24, 36, 37, 40], data on directly measuring AVVR jets remain limited in the pediatric CHD population [24]. Direct measurement of the regurgitant jet has a theoretical advantage in that it is a single measurement unaffected by the aforementioned compounded errors from the indirect methods. We sought to determine the utility of direct measurement of AVVR using 4DF CMR in pediatric patients with CHD compared to currently used indirect measurements. We hypothesized that: (1) direct measurement of the AVVR jet (JET) is accurate and reliable compared to the current clinical standard—the VOL method; and (2) the JET provides a better method of internal validation than the annular inflow method (AIM).

Material and methods

In this retrospective cohort study, we identified all pediatric patients referred for evaluation of AVVR by CMR with 2D planimetry and 4DF acquisitions at our institution from February 2013 to January 2019. Exclusion criteria included patients with ventricular level shunts, more than one outflow tract from the respective ventricle, and more than trace regurgitation (≥5%) of the respective semilunar valve as measured by 4DF CMR. Although each method of AVVR assessment accounts for semilunar valve regurgitation, there is some variability in that assessment. In order to ensure that any variability identified reflects AV valve regurgitation assessment and not semilunar valve assessment, we excluded patients with significant (mild or worse) regurgitation of the semilunar valve ipsilateral to the regurgitant AV valve. A cohort of 67 patients met inclusion criteria. Of these, seventeen (25%) were excluded due to the presence of mild or greater semilunar valve regurgitation. An additional six (9%) were excluded due to concerns related to image quality including excessive aliasing on 4DF (n = 1), movement during 4DF acquisitions (n = 2), and lack of visible AVVR jets (n = 3). No subjects were excluded due to ventricular level shunt or dual-outflow tract; all subjects had a Qp:Qs ~ 1 except for two subjects with hypoplastic left heart syndrome and a bi-directional Glenn palliation with a Qp:Qs of 0.55–0.77. Forty-four patients comprised the study cohort (Table 1). If a subject had multiple CMR scans during the 6-year inclusion period, the most recent CMR scan was included such that each subject was represented only once in the dataset. For descriptive purposes of this study, in patients with a history of repaired AV canal, the presence of left-sided regurgitation was categorized as mitral regurgitation and right-sided regurgitation was categorized as tricuspid regurgitation. Our local IRB approved this study with waived informed consent.

Table 1 Patient Characteristics

Image acquisition

The magnetic field, intravenous contrast, and technical parameters were prescribed by radiologists with expertise in CMR as per routine clinical practice. CMR exams were performed on 1.5 T CMR system (General Electric Healthcare, Waukesha, Wisconsin, USA; Optima 450 W) and 3 T (General Electric Healthcare, GE MR750) scanners. At our institution, it is standard practice with 4DF CMR to use ferumoxytol (Feraheme; AMAG Pharmaceuticals, Waltham, Massachusetts, USA) for 3 T and gadolinium-based contrasts (Gadobenate dimeglumine [Multihance, Bracco Diagnostics, Monroe, New Jersey, USA]; Gadofosveset) for 1.5 T scans to optimize signal-to-noise ratio [41].

Two-dimensional CMR planimetry utilized short-axis, balanced steady-state free-precession (bSSFP) and PC sequences with retrospective gating. Short-axis slices were obtained with a breath hold using one signal average and parallel imaging acceleration; 12–14, 8 mm slices spanned the ventricles at 20 phases per cardiac cycle. Matrix and temporal resolution parameters were adjusted to accommodate breath holding capacity. In patients who could not breath hold, multiple signal averages were employed. 2D PC measurements of atrioventricular forward flow (AVFF) were obtained with a velocity encoding (VENC) of 150 m/s as default, then increased until no aliasing was noted. The following parameters were used: temporal resolution 36.4 msec (range 21–54), acquired spatial resolution 256 × 192, and slice thickness 10 mm. There was no adjustment for through-plane motion for 2D PC measurements of AVFF. 2D PC measurements of AVFF were available for only 13/44 (30%) patients, thus 4DF CMR AVFF measurements via a static plane were obtained as a substitute for the purposes of this study.

4DF acquisitions were obtained as the last sequence of each CMR study following administration of contrast in the majority of patients (Table 1). Non-contrast enhanced 4DF acquisition was obtained in one subject with a historical allergy to gadolinium-based contrast. 1.5 T CMR images were obtained with the following parameters, mean (range): flip angle of 15*, reconstructed spatial resolution of 1.2 (0.8–1.5) × 1.4 (0.8–1.8) × 2.1 (0.9–3) mm3, echo time 1.9 (1.5–2.1) msec, repetition time 4.4 (3.6–5.1) msec, views-per-segment of 3 (2–5) depending on heart rate, temporal resolution of 62.5 msec (28.6–83.6), bandwidth of ±63.3 kHz (62–125), and VENC parameters of 300 (250–450 m/sec) chosen to avoid aliasing. The base acceleration factor used was 5 × 3 with motion correction performed by leveraging the velocity encoding gradients as intrinsic navigators and soft-gating the data, for an approximate overall acceleration factor of 30. 3 T CMR images were obtained with the following parameters, mean (range): flip angle of 15*, reconstructed spatial resolution of 0.84 (0.7–1.2) × 0.9 (0.7–1.6) × 1.7 (1.2–2.8) mm3, TE 1.8 (1.7–2.1) msec, TR 4.1 (3.7–4.8) msec, true temporal resolution of 32.4 msec (18.3–58.6), bandwidth of ±83.3 kHz (63–100), total acceleration factor of 2.0 × 2.0, and VENC 300 (250–550 m/sec) chosen to avoid aliasing. Retrospective gating was used to obtain a total of 20 cardiac phases for 1.5 T and 20–30 phases for 3 T scanners. Due to clinical workflow, many of our 3 T exams are performed sedated or with general anesthesia and the vast majority of the exams performed on the 1.5 T magnet are performed unsedated. For this reason, there is a greater effort to accelerate sequences performed on our 1.5 T magnet.

To minimize coherent artifacts from respiratory motion, a pseudo-random view-ordering and sampling was used for 4DF [42]. More specifically, a variable-density Poisson disc sampling mask was first generated [43]. Each (ky,kz)-sample was then grouped into radial spokes and ordered according to the golden-ratio [44]. Image reconstruction was performed with a combined parallel-imaging compressed sensing algorithm, with soft-gating of the source data based on intrinsic respiration motion navigation [42, 43, 45]. Temporal and spatial sparsity were enforced. Post-processing software corrected for phase errors by estimating the background phase from a polynomial fit on the phase of the static tissue.

Image analysis

Subjects were analyzed in a blinded fashion by KGJ, a pediatrics resident with 2 years research experience in CMR post-processing. For training, a series of 10 subjects were blindly measured with feedback from a cardiologist with > 8 years clinical experience in CMR (SAM). The data from these feedback sessions were not included in the study. Subjects were placed in a random order by a random number generator for analysis such that the effect of training would be minimized. A random number generator was used to select 20 subjects for which measurements were repeated with a minimum of 2 weeks between analyses to obtain intra- and inter-rater reliability (KGJ, SAM).

2D planimetric images were analyzed on QMassMR (MEDIS; Leiden, the Netherlands). A parallel stack of short-axis images were manually traced for endocardial borders to calculate a volume for each image plane, which were then summed to produce end-diastolic volumes (EDV) and end-systolic volumes (ESV). Both the 2- and 4-chamber views were used to cross-reference for ventricular planimetry [16]. A slice was considered to contain primarily atrium when < 50% of the blood volume was encircled with myocardium, outflow tracts were included in ventricular volumes up to the semilunar valve cusps, and trabeculations and papillary muscles were considered part of the blood pool [14]. Stroke volume (SV) was calculated as EDV-ESV for each respective ventricle. 2D PC measurements of AVFF were analyzed on QFlowMR (MEDIS). A region of interest was traced around the AV valve with the velocity therein integrated to determine the flow volume [15]. A sub-group analysis was performed between 2D PC AVFF and 4DF static AVFF. However, for homogeneity across the study cohort, all calculations of AIMstat utilized the 4DF CMR measurement of AVFF.

4DF analyses were performed using cloud-based software (Arterys, San Francisco, California, USA). Measurements of aortic and pulmonary artery flow were made at the level of the sinotubular junction for the aorta and midway between the pulmonary valve and pulmonary artery bifurcation, respectively, as per published recommendations [14, 28]. With reference to the 2- and 4-chamber cross-sections, an initial plane was created at end-systole at the mid-leaflet level of the AV valve and orthogonal to flow [16, 27]. Flow was visualized by velocity vectors depicting blood flow directionality in real-time and color-coded for magnitude. Flow through the AV static plane was semi-automatically traced by the software during diastole and manually corrected, as needed. The retrospective valve-tracking AV plane was manually adjusted through diastole to remain near the mid-leaflet level and orthogonal to flow [37], with similar semi-automated tracing of the AV inflow as with the static plane. The regurgitant jet was measured by a plane perpendicular to the jet immediately distal to regions of aliasing, if present [24, 40]. In cases of multiple jets, separate planes were created for each jet and the volume of each jet summed. Care was taken to ensure tracings for each individual jet did not overlap. Time necessary to complete post-processing was recorded for both AIMs and JET.

Our study compares four methodologies calculating regurgitant volume (RVol). Given the clinical utility of regurgitant fraction (RF), we report RF as our outcome. RF was calculated as the quotient of AVVR and AV inflow by the formula RVol/[RVol + semilunar valve net flow (SLNF)]× 100 based on conservation of mass dictating that net inlet and outlet flows are equal. RF was classified as mild (< 30%), moderate (30–39%), moderate-severe (40–49%), or severe (> 50%) [13]. The four methods of calculating RVol were as follows (Figs. 1 and 2; Supplementary videos):

  1. 1.

    Volumetric method (VOL) = stroke volume by 2D bSSFP – forward flow across the semilunar valve by 4DF PC

  2. 2.

    Annular inflow method (AIMstat) = AVFF, using a static plane, by 4DF PC – SLNF by 4DF PC

  3. 3.

    Annular inflow method (AIMtrack) = AVFF, using a valve-tracking plane, by 4DF PC – SLNF by 4DF PC

  4. 4.

    Direct measurement of the AVVR jet (JET) by 4DF PC

Fig. 1

Graphic and mathematical depiction of the indirect methods calculating atrioventricular valve regurgitation (AVVR). a Ventricular stroke volume (SV) is the sum of AVVR and semilunar forward flow (SLFF); b AVVR is derived from the conservation of mass which assumes that atrioventricular net flow (AVNF) equals semilunar net flow (SLNF) in the absence of an intracardiac shunt

Fig. 2

4DF CMR on Arterys of the direct jet method (a, b) and the indirect annular inflow method (AIMtrack) by valve tracking planes (c, d). Examples of tricuspid regurgitation (row a) and mitral regurgitation (row b) are presented. Rows (c) and (d) represent four-chamber and two-chamber views of AIMtrack

Statistical analysis

A power analysis demonstrated that for a paired t-test, 44 subjects would be necessary with alpha of 0.05 and beta of 10% (power 90%) to detect a 10% difference in regurgitant volume between subjects, allowing for 20% variance (effect size: 0.5).

Continuous data were described as mean (±standard deviation (SD)) and median (interquartile range (IQR)) as appropriate based on normality assessment with Shapiro-Wilk tests and histograms. Correlation between modalities was determined via Pearson’s (r) or Spearman’s (ρ) correlation coefficients, as appropriate. Variance between measurements was described as median difference (IQR) and absolute median difference (IQR) or mean difference (±SD) and absolute mean difference (±SD), as appropriate. The presence of any systematic difference between measurements was determined via the Wilcoxon signed rank test or Student’s paired t-test. All differences were calculated in the order presented, e.g. VOL vs. AIM calculated as VOL - AIM. Bland-Altman plots were used to visualize and compare agreement between methods [46, 47]. Bland-Altman plots show variance as limits of agreement (LOA), calculated as mean ± SDx1.96. However, this does not appropriately represent our data given the skewed, non-normal distribution, thus consideration should be given to the median difference (IQR) provided in the table as additional representation of the distribution of data. Linear regression scatter plots were used to further visualize distribution and correlation of data. Spearman’s correlation coefficients are presented on the linear regression analyses as the non-parametric complement.

Reliability was assessed with intra- and inter-rater repeated measurements (KGJ, SAM) [48]. Intra-class correlation coefficients (ICC) were calculated using a two-way mixed model with absolute agreement, reporting the single measures ICC with 95% confidence interval (CI) [49]. Statistical significance was considered if a two tailed p-value was < 0.05. All statistical analyses were performed using SPSS (v.25, Statistical Package for the Social Sciences, International Business Machines, Inc., Armonk, New York, USA).


Forty-four pediatric patients (11.4 ± 6.3 years; 23 (52%) female) with diverse CHD diagnoses were included in this study (Table 1). Eighteen (41%) had mitral regurgitation. To tolerate CMR, seven (16%) subjects underwent CMR with general anesthesia and four (9%) had conscious sedation. Five additional subjects (11%) were sedated due to simultaneous procedures or were already sedated prior to CMR. Demographic characteristics are further described in Table 1. We found no significant differences in these characteristics between the populations with mitral and tricuspid regurgitation. The majority of subjects (77%) had one regurgitant jet. Aliasing within the regurgitant jet was common (23/44, 52%) for both mitral and tricuspid regurgitation (p = 0.112). Regurgitant fractions ranged from 0.5 to 79% as measured by VOL. The subject with 79% RF was measured similarly by the AIM methods (82–83%). This subject passed away shortly after the exam. The majority of subjects had mild RF; however, five subjects by VOL, six by AIMstat, and seven by AIMtrack were calculated to have negative regurgitant fractions (Table 2). Heart rates were similar between 2D and 4DF scans: 80.0 (± 19.7) bpm for 2D bSSFP (n = 44) vs. 85.2 (± 18.4) bpm for 4DF CMR, p = 0.308; 86.6 (± 21.6) bpm for 2D PC AVFF (n = 13) vs. 89.5 (± 20.0) bpm for 4DF CMR, p = 0.253. Post-processing times for AVVR using 4DF CMR were acceptable for clinical practice: AIMstat 2.8 ± 0.7 min, AIMtrack3.7 ± 1.9 min, and JET 3.1 ± 2.1 min (p = 0.114). 4DF acquisition time was 8.4 (7.6–9.7) and 14.7 (12.1–15.2) (p = 0.001) minutes for 1.5 T and 3 T studies, respectively.

Table 2 Comparison of the RF as measured by each method

Comparison between methods to assess regurgitant fraction

Measurement of RF by JET was similar to VOL (median difference (IQR) -1.5% (− 8.3–7.2%), p = 0.62) with moderate-strong correlation (ρ = 0.73, p < 0.001) (Table 3). While there were moderate-strong correlations between VOL and both AIM methods (ρ = 0.69–0.70, p < 0.001), the AIM methods using static (AIMstat) and valve-tracking planes (AIMtrack) were significantly different from VOL and underestimated RF with median differences of 4.3% [− 2.0–15.7%] (p = 0.027) and 6.9% [0.2–15.0%] (p = 0.006), respectively. These methods similarly underestimated RF relative to JET, though to a slightly lesser degree, with median differences of 3.6% [− 12.0–1.8%] (p = 0.005) and 5.8% [− 13.7–0.3%] (p < 0.001), respectively. AIMstat and AIMtrack were highly correlated (ρ = 0.98, p < 0.001). RF by AIMstat was slightly larger than AIMtrack by a median difference (IQR) of 1.7% [0.1–4.3%] (p < 0.001).

Table 3 Comparison of regurgitant fraction (RF) measured by the indirect and direct methods

In assessing internal consistency, BA and scatter plots comparing all four methods demonstrated narrower limits of agreements and more precise spread of data for the JET method compared to VOL and AIM methods than the VOL method compared to JET and AIM methods (Figs. 3 and 4).

Fig. 3

Bland Altman plots comparing the 4 methods in this study: the indirect methods (VOL and both AIMs) and the direct method (JET). The limits of agreements (dashed lines) are narrower for the JET comparisons (c-e) than for the VOL comparisons (a-c). The mean difference is shown as a solid line. Mitral regurgitation (MR) is denoted by red points, tricuspid regurgitation (TR) is denoted by blue points. VOL = volumetry method, AIMstat = annular inflow method by static plane, AIMtrack = annular inflow method by valve-tracking plane, JET = direct measurement of jet

Fig. 4

Linear regression plots comparing the 4 methods of this study: the indirect methods (VOL and both AIMs) and the direct method (JET). Given non-parametric distribution of data, Spearman’s correlation coefficients are substituted for Pearson’s. Mitral regurgitation (MR) is denoted by red points, tricuspid regurgitation (TR) is denoted by blue points. VOL = volumetry method, AIMstat = annular inflow method by static plane, AIMtrack = annular inflow method by valve-tracking plane, JET = direct measurement of jet

For the 13 subjects in whom 2D PC AVFF data was available, a sub-group analysis was performed. AVFF measurements were not significantly different between 2D PC and 4DF CMR (mean difference 0.4 ± 9.5 mL/beat, p = 0.892) and were highly correlated (Pearson’s r = 0.962, p < 0.001). AIMstat using 2D PC AVFF calculated a lower RF than AIMstat using 4DF static AVFF though this difference was non-significant (median difference (IQR) 2.8% (− 8.1–5.5), p = 0.701)). As a result, in this smaller cohort, 2D AIMstat correlated worse with VOL (ρ =0.736, p = 0.004) than 4DF AIMstat with VOL (ρ =0.824, p = 0.001). AIMstat by both modalities underestimated RF relative to VOL by median differences of 9.1–11.7% (p < 0.05).


Intra- and inter-observer reliability was tested on 20 randomly selected subjects (45%): 12 had tricuspid regurgitation and 8 had mitral regurgitation. Intra-observer correlations for the four methods were excellent (ICC 0.97–0.98) with no significant differences between measurements (p = 0.88–0.97) (Table 4). Mean differences were all close to zero with narrow LOAs (Fig. 5). Inter-observer correlations for the 4 methods were also excellent (ICC 0.94–0.96). Measurements of RF were not significantly different between raters using the AIM and JET methods (p = 0.22–0.47), with small mean differences and narrow LOAs. However, inter-observer measurements of VOL were significantly different (p = 0.046), although the clinical significance of this difference was small (2.41% ± 5.05) and the variance of this difference was smaller than inter-observer differences for JET and AIM methods (Fig. 5). Intra- and inter-observer analysis of planimetry measurements demonstrated excellent reliability of left ventricular (LV) and right ventricular (RV) volumes (ICC = 0.99) with small, clinically insignificant, median differences (Table 4).

Table 4 Intra- and inter-observer reliability
Fig. 5

Bland Altman plots comparing the intra- and inter-observer reliability measurements (a-d and e-h, respectively) using the indirect and direct methods measuring atrioventricular valve regurgitation. Mean difference is represented with a solid line; limits of agreement are represented with dashed lines. Mitral regurgitation (MR) is denoted by red points, tricuspid regurgitation (TR) is denoted by blue points. VOL = volumetry method, AIMstat = annular inflow method by static plane, AIMtrack = annular inflow method by valve-tracking plane, JET = direct measurement of jet

Mitral vs tricuspid regurgitation

A sub-group analysis found that agreement between VOL and JET measurements was not affected by laterality of AVVR (Table 5). However, JET had better precision with VOL and AIM methods for assessment of tricuspid RF (ρ = 0.66–0.85, p < 0.001; lower measurement variability) than VOL with JET and AIM methods (ρ = 0.58–0.66, p < 0.001). Conversely, the JET method was less precise with VOL and AIM for assessment of mitral RF (ρ = 0.66–0.69, p < 0.001; higher measurement variability) than VOL with JET and AIM (ρ = 0.66–0.79, p < 0.001) (Table 5). Measurements of intra- and inter-observer reliability were similar for mitral and tricuspid AVVR.

Table 5 Comparison of indirect and direct methods by laterality of AVVR


We performed a retrospective study designed to compare the accuracy and reliability of directly measuring AVVR in pediatric CHD with 4DF CMR compared to the standard indirect methods. There were three major findings of our study. (1) Our data demonstrate that assessment of AVVR by JET was overall the most precise measurement, particularly in subjects with tricuspid regurgitation. Though all four methods performed well, the JET correlated with VOL better than AIM and JET correlated with AIM better than VOL. Unlike AIM, the JET method was found to be accurate compared to VOL -- the clinical standard. Further, the JET method showed excellent inter- and intra-observer reliability in a diverse population of pediatric CHD, unaffected by the presence of aliasing or laterality of AVVR. (2) VOL had weaker correlations and larger measurement variability compared with the JET and AIM methods than JET vs. VOL and AIM methods. Though intra- and inter-observer reliability of VOL by ICC were excellent, inter-observer reliability measurements showed a small but statistically significant difference between observers. (3) Despite strong correlations, the AIM using static and valve-tracking techniques underestimated AVVR relative to the JET and VOL methods. Though the degree of this underestimation was small in most subjects, these findings support JET as an alternative measure of internal validation in measuring AVVR.

Measurement of AVVR

This is the first study demonstrating validity of the JET method to accurately and reliably measure AVVR compared to multiple indirect methods in a diverse pediatric cohort with CHD. Our findings support the results of prior work on the JET method in other patient populations. A retrospective study of 21 adults without CHD found that RF directly measured by 4DF CMR was highly reliable and accurate compared to the VOL method [40]. The correlation and measurement variability noted between the JET and VOL methods in our cohort are similar to prior data from pediatric and adult cohorts [24, 29].

Although this is the first such report in children, the JET method by 4DF CMR has been previously found in adults to have high accuracy and reliability relative to the VOL method, particularly in measuring tricuspid regurgitation [40]. 4DF CMR post-processing allows for visualization of flow to aid in the positioning of measurement planes through the use of velocity vectors [37]. Prior work has demonstrated improved accuracy for the AIM method when the atrioventricular plane is placed at the peak inflow velocity as opposed to the valvular plane [37, 50]. The importance of a measurement plane perpendicular to flow likely extends to JET planes and may explain the relatively worse correlation between measurements of mitral RF between the JET and the VOL and AIM methods. Tricuspid regurgitant jets tend to be more central and laminar in orientation as opposed to mitral jets which are more commonly eccentric with a large angle change during systole [40]. In a cohort of 32 children and adults with repaired atrioventricular septal defect (AVSD) and left-sided regurgitation, the regurgitant jets were found to be non-circular, dynamic, and eccentric with a median angulation change of 30–36° during systole [24]. These features increase the technical difficulty of maintaining an orthogonal plane to the mitral regurgitant jet through systole. As can be seen in a subject with repaired AVSD and resultant mitral cleft (Fig. 2b), the large eccentric regurgitant jet which projects along the inferior mural aspect of the left atrium throughout systole complicates creating a true cross-sectional plane. Five of the 18 (28%) subjects in our cohort with mitral regurgitation had a history of AVSD which may have affected accuracy of our JET measurements despite excellent reliability. Our data highlight the clinical applicability of the JET method in pediatric CHD requiring evaluation of tricuspid regurgitation. Although the results were also promising in cases of mitral regurgitation, considerably eccentric or dynamic jets may affect the accuracy of the JET method.

Our initial intent was to use VOL as the clinical standard to which to compare JET and AIM methods. Upon analysis of the data we found that all four methods were fairly consistent, but that VOL was not the most precise measurement -- which raises the question of its role as the clinical standard. The accuracy of VOL is affected by measurement errors inherent in planimetry, particularly given the practice variation in basal slice inclusion and contour selection, which may have contributed to lower measurement precision [16, 51]. However, our planimetry reliability analyses found excellent intra- and inter-observer reliability for both LV and RV measurements. Similarly, our results demonstrated excellent reliability for the VOL method, supporting the results from multiple prior works [9, 17, 29, 40]. Two additional practical concerns with the VOL method arose from our data. In our cohort, VOL classified more subjects with moderate or severe regurgitation than the JET and AIM methods. This may result in greater consideration for surgery when VOL is used to measure regurgitation. Furthermore, a limitation to the use of VOL as the clinical standard are cases in which the indirect calculation results in a negative RF (Table 2). Negative RFs were found in 5/44 (11%) subjects by the VOL method as well as in a separate 6/44 (14%) and 7/44 (16%) by AIMstat and AIM track, respectively.

The AIM methods systematically underestimated RF compared to VOL and JET methods. Though these differences may be clinically insignificant in certain patients, for subjects with mild regurgitation (~ 60% of our cohort), these differences represented up to 25% of their total RF. AIMstat measured slightly but consistently larger than AIMtrack, consistent with prior studies demonstrating that static AV planes overestimate RVol and RF relative to tracking planes [23, 37, 52]. The differences found in our study were smaller than prior reports and may be due to our methodology; determination of a “static plane” by 4DF CMR has significantly more flexibility than a standard 2D CMR scan and may have increased accuracy of the measurements. This is supported by our sub-group analysis demonstrating that AIMstat calculated using 2D PC AVFF measurements correlated worse with and had a larger median difference from VOL than AIMstat calculated using 4DF CMR static AVFF. Prior work using 4DF CMR and retrospective valve tracking annular inflow methods do not report their calculated AVVR as outcomes, instead comparing net inlet and outlet flows for internal validation, which limits direct comparison to our results as well as general clinical applicability [22, 25]. Recent work has demonstrated feasibility of an automatic valve-tracking 4DF CMR technique with improved reliability and internal consistency in measuring net valve flow across all four cardiac valves compared to manual valve-tracking technique in a large cohort of subjects with CHD [36]. However, their RF measurements were not compared to a clinical standard (such as VOL) or outcome measures. Future work assessing the accuracy of the automatic valve-tracking AIM method may demonstrate improved accuracy than found in our study with manual valve-tracking.

Logistical advantages of 4DF CMR

2D CMR requires technical expertise from technologists and physicians to prescribe AV planes during the acquisition in patients with complex CHD anatomy, resulting in scan durations of 1–1.5 h [41, 53]. This has important implications on anesthetic requirements in pediatrics and on clinical efficiency. 4DF CMR, as a single acquisition with all planes created during post-processing, takes ~ 10 min after an initial localizer sequence. Acquisition of standard 2D PC requires multiple localizing sequences to achieve optimal orthogonal planes. Children are more likely to move in-between sequences, requiring repeat localizer sequences and longer exam times. This has resulted in the adoption of 4DF CMR for acquisition of all flow measurements at our institution, though 2D cine acquisitions are still necessary for planimetry.

Our post-processing analysis times for the AIM and JET methods were short and represent an opportunity to improve clinical flow and resource utilization in the MRI workflow. Our analysis time for the AIMtrack method was significantly shorter than prior reports of 15–35 min per patient, likely due to the use of semi-automated software that adjusted to through plane motion [23, 25]. The JET method analysis time was relatively short (3.1 ± 2.1 min) irrespective of number and morphology of regurgitant jets.


Several limitations were present in our study. VOL in this study utilized 2D planimetry measurements and 4DF PC semilunar flow measurements, which precludes comparison of a true 2D VOL measurement to the 4DF JET. However, 4DF PC measurements of semilunar flow have been previously validated with excellent internal consistency and accuracy compared to 2D PC CMR [22, 30, 31, 35, 39], thus we do not believe this negatively impacted the validity of our results. We excluded subjects with significant semilunar regurgitation and our data may not be generalizable to those populations. Arterial encoding speeds were utilized in our cohort as part of our institution’s clinical practice based off prior published findings demonstrating reliable quantification of venous blood flow at arterial VENCs with the use of IV contrast, although this may have contributed to underestimation of the AIM method [41, 54]. It is not our clinical practice to perform multiple 4DF sequences at different VENC settings, though this may allow for more accurate data. Future application of phase unwrapping software may allow for a single, low-VENC 4DF sequence. Despite arterial VENCs, aliasing of regurgitant jets was common. However, tracing the jets distal to the aliasing segment allowed for accurate and reproducible data. We employ contrast agents for all our 4DF acquisitions. Recent research has found dose-dependent retention of gadolinium-based contrast in the brains of patients despite normal renal function, though long-term effects from chronic exposure remain unknown [55]. Although ferumoxytol is used clinically at an increasing number of centers for cardiac imaging, there remains a black box warning in pediatric imaging due to the small risk of adverse reactions, most notably hypotension [56]. Further study is necessary to clarify the risk:benefit ratio of contrast administration for these studies. Although our methodology for calculating AVVR differed slightly from published recommendations we accounted for even a small amount of semilunar regurgitation in order to optimize accuracy when comparing methodologies [13, 16, 53, 57]. Lastly, this study did not validate direct AVVR quantification against clinical outcome measures, as this was beyond the scope of the study.


In a cohort of pediatric CHD, our findings support direct measurement of the regurgitant jet by 4DF CMR as an accurate and reliable method of measuring AVVR. In our cohort, the JET method was a superior method of internal validation to the VOL method than the AIM method by static- or valve-tracking- planes. We recommend at least 2 methods to measure AVVR. This redundancy exemplifies the benefits of 4DF CMR, and lends credence to the reported data. The JET method performed well in this heterogenous group, many of which had multiple, eccentric regurgitant jets. The slightly superior performance seen in subjects with tricuspid regurgitation compared to those with mitral regurgitation may be due to particularly eccentric or dynamic mitral jets. Future research should focus on validating our results in a larger, multicenter cohort of pediatric patients with CHD as well as correlation with outcomes including exercise capacity, development of ventricular dysfunction, surgical intervention, and mortality.

Availability of data and materials

The data sets used and/or analyzed during the current study are available from the corresponding author on reasonable request.


4DF 4D flow AIMstat :

Annular inflow method by static plane

AIMtrack :

Annular inflow method by valve-tracking plane


Atrioventricular valve


Atrioventricular valve forward flow


Atrioventricular septal defect


Atrioventricular valve regurgitation




Balanced steady-state free-precession


Congenital heart disease


Confidence interval


Cardiovascular magnetic resonance


End-diastolic volume


End-diastolic volume index


End-systolic volume


End-systolic volume index


Intra-class correlation coefficient


Interquartile range


Direct measurement of AVVR jet


Limits of agreement


Left ventricle/left ventricular


Mitral regurgitation


Phase contrast


Regurgitant fraction


Right ventricle/right ventricular


Regurgitant volume


Standard deviation


Semilunar valve net flow


Stroke volume


Tricuspid regurgitation


Velocity encoding


Volumetric method


  1. 1.

    Driscoll DJ, Offord KP, Feldt RH, Schaff HV, Puga FJ, Danielson GK. Five- to fifteen-year follow-up after Fontan operation. Circulation. 1992;85(2):469–96.

    CAS  PubMed  Article  Google Scholar 

  2. 2.

    Bokma JP, Winter MM, Oosterhof T, Vliegen HW, van Dijk AP, Hazekamp MG, et al. Severe tricuspid regurgitation is predictive for adverse events in tetralogy of Fallot. Heart. 2015;101(10):794–9.

    PubMed  Article  Google Scholar 

  3. 3.

    Oliver JM, Gallego P, Gonzalez AE, Garcia-Hamilton D, Avila P, Yotti R, et al. Risk factors for excess mortality in adults with congenital heart diseases. Eur Heart J. 2017;38(16):1233–41.

    PubMed  Google Scholar 

  4. 4.

    Prieto LR, Hordof AJ, Secic M, Rosenbaum MS, Gersony WM. Progressive tricuspid valve disease in patients with congenitally corrected transposition of the great arteries. Circulation. 1998;98(10):997–1005.

    CAS  PubMed  Article  Google Scholar 

  5. 5.

    Ono M, Cleuziou J, Pabst von Ohain J, Beran E, Burri M, Strbad M, et al. Atrioventricular valve regurgitation in patients undergoing total cavopulmonary connection: impact of valve morphology and underlying mechanisms on survival and reintervention. J Thorac Cardiovasc Surg. 2018;155(2):701–9 e6.

    PubMed  Article  Google Scholar 

  6. 6.

    Dennis M, Zannino D, du Plessis K, Bullock A, Disney PJS, Radford DJ, et al. Clinical outcomes in adolescents and adults after the Fontan procedure. J Am Coll Cardiol. 2018;71(9):1009–17.

    PubMed  Article  Google Scholar 

  7. 7.

    Hoohenkerk GJ, Bruggemans EF, Rijlaarsdam M, Schoof PH, Koolbergen DR, Hazekamp MG. More than 30 years’ experience with surgical correction of atrioventricular septal defects. Ann Thorac Surg. 2010;90(5):1554–61.

    PubMed  Article  Google Scholar 

  8. 8.

    Honjo O, Atlin CR, Mertens L, Al-Radi OO, Redington AN, Caldarone CA, et al. Atrioventricular valve repair in patients with functional single-ventricle physiology: impact of ventricular and valve function and morphology on survival and reintervention. J Thorac Cardiovasc Surg. 2011;142(2):326–35 e2.

    PubMed  Article  Google Scholar 

  9. 9.

    Uretsky S, Gillam L, Lang R, Chaudhry FA, Argulian E, Supariwala A, et al. Discordance between echocardiography and MRI in the assessment of mitral regurgitation severity: a prospective multicenter trial. J Am Coll Cardiol. 2015;65(11):1078–88.

    PubMed  Article  Google Scholar 

  10. 10.

    Hamilton-Craig C, Strugnell W, Gaikwad N, Ischenko M, Speranza V, Chan J, et al. Quantitation of mitral regurgitation after percutaneous MitraClip repair: comparison of Doppler echocardiography and cardiac magnetic resonance imaging. Ann Cardiothorac Surg. 2015;4(4):341–51.

    PubMed  PubMed Central  Google Scholar 

  11. 11.

    Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Guyton RA, et al. 2014 AHA/ACC guideline for the Management of Patients with Valvular Heart Disease: executive summary: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. Circulation. 2014;129(23):2440–92.

    PubMed  Article  Google Scholar 

  12. 12.

    Grant AD, Thavendiranathan P, Rodriguez LL, Kwon D, Marwick TH. Development of a consensus algorithm to improve interobserver agreement and accuracy in the determination of tricuspid regurgitation severity. J Am Soc Echocardiogr. 2014;27(3):277–84.

    PubMed  Article  Google Scholar 

  13. 13.

    Zoghbi WA, Adams D, Bonow RO, Enriquez-Sarano M, Foster E, Grayburn PA, et al. Recommendations for noninvasive evaluation of native valvular regurgitation: a report from the American Society of Echocardiography developed in collaboration with the Society for Cardiovascular Magnetic Resonance. J Am Soc Echocardiogr. 2017;30(4):303–71.

    PubMed  PubMed Central  Article  Google Scholar 

  14. 14.

    Schulz-Menger J, Bluemke DA, Bremerich J, Flamm SD, Fogel MA, Friedrich MG, et al. Standardized image interpretation and post processing in cardiovascular magnetic resonance: Society for Cardiovascular Magnetic Resonance (SCMR) board of trustees task force on standardized post processing. J Cardiovasc Magn Reson. 2013;15:35.

    PubMed  PubMed Central  Article  Google Scholar 

  15. 15.

    Polte CL, Bech-Hanssen O, Johnsson AA, Gao SA, Lagerstrand KM. Mitral regurgitation quantification by cardiovascular magnetic resonance: a comparison of indirect quantification methods. Int J Cardiovasc Imaging. 2015;31(6):1223–31.

    PubMed  Article  Google Scholar 

  16. 16.

    Krieger EV, Lee J, Branch KR, Hamilton-Craig C. Quantitation of mitral regurgitation with cardiac magnetic resonance imaging: a systematic review. Heart. 2016;102(23):1864–70.

    PubMed  Article  Google Scholar 

  17. 17.

    Cawley PJ, Maki JH, Otto CM. Cardiovascular magnetic resonance imaging for valvular heart disease: technique and validation. Circulation. 2009;119(3):468–78.

    PubMed  Article  Google Scholar 

  18. 18.

    Myerson SG, d'Arcy J, Christiansen JP, Dobson LE, Mohiaddin R, Francis JM, et al. Determination of clinical outcome in mitral regurgitation with cardiovascular magnetic resonance quantification. Circulation. 2016;133(23):2287–96.

    PubMed  Article  Google Scholar 

  19. 19.

    Cawley PJ, Hamilton-Craig C, Owens DS, Krieger EV, Strugnell WE, Mitsumori L, et al. Prospective comparison of valve regurgitation quantitation by cardiac magnetic resonance imaging and transthoracic echocardiography. Circ Cardiovasc Imaging. 2013;6(1):48–57.

    PubMed  Article  Google Scholar 

  20. 20.

    Penicka M, Vecera J, Mirica DC, Kotrc M, Kockova R, Van Camp G. Prognostic implications of magnetic resonance-derived quantification in asymptomatic patients with organic mitral regurgitation: comparison with Doppler echocardiography-derived integrative approach. Circulation. 2018;137(13):1349–60.

    PubMed  Article  Google Scholar 

  21. 21.

    Harris AW, Krieger EV, Kim M, Cawley PJ, Owens DS, Hamilton-Craig C, et al. Cardiac magnetic resonance imaging versus transthoracic echocardiography for prediction of outcomes in chronic aortic or mitral regurgitation. Am J Cardiol. 2017;119(7):1074–81.

    PubMed  Article  Google Scholar 

  22. 22.

    Hsiao A, Tariq U, Alley MT, Lustig M, Vasanawala SS. Inlet and outlet valve flow and regurgitant volume may be directly and reliably quantified with accelerated, volumetric phase-contrast MRI. J Magn Reson Imaging. 2015;41(2):376–85.

    PubMed  Article  Google Scholar 

  23. 23.

    Driessen MMP, Schings MA, Sieswerda GT, Doevendans PA, Hulzebos EH, Post MC, et al. Tricuspid flow and regurgitation in congenital heart disease and pulmonary hypertension: comparison of 4D flow cardiovascular magnetic resonance and echocardiography. J Cardiovasc Magn Reson. 2018;20(1):5.

    PubMed  PubMed Central  Article  Google Scholar 

  24. 24.

    Calkoen EE, Westenberg JJ, Kroft LJ, Blom NA, Hazekamp MG, Rijlaarsdam ME, et al. Characterization and quantification of dynamic eccentric regurgitation of the left atrioventricular valve after atrioventricular septal defect correction with 4D flow cardiovascular magnetic resonance and retrospective valve tracking. J Cardiovasc Magn Reson. 2015;17:18.

    PubMed  PubMed Central  Article  Google Scholar 

  25. 25.

    Westenberg JJ, Roes SD, Ajmone Marsan N, Binnendijk NM, Doornbos J, Bax JJ, et al. Mitral valve and tricuspid valve blood flow: accurate quantification with 3D velocity-encoded MR imaging with retrospective valve tracking. Radiology. 2008;249(3):792–800.

    PubMed  Article  Google Scholar 

  26. 26.

    van der Hulst AE, Westenberg JJ, Kroft LJ, Bax JJ, Blom NA, de Roos A, et al. Tetralogy of fallot: 3D velocity-encoded MR imaging for evaluation of right ventricular valve flow and diastolic function in patients after correction. Radiology. 2010;256(3):724–34.

    PubMed  Article  Google Scholar 

  27. 27.

    Fratz S, Chung T, Greil GF, Samyn MM, Taylor AM, Valsangiacomo Buechel ER, et al. Guidelines and protocols for cardiovascular magnetic resonance in children and adults with congenital heart disease: SCMR expert consensus group on congenital heart disease. J Cardiovasc Magn Reson. 2013;15:51.

    PubMed  PubMed Central  Article  Google Scholar 

  28. 28.

    Myerson SG. Heart valve disease: investigation by cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2012;14:7.

    PubMed  PubMed Central  Article  Google Scholar 

  29. 29.

    Myerson SG, Francis JM, Neubauer S. Direct and indirect quantification of mitral regurgitation with cardiovascular magnetic resonance, and the effect of heart rate variability. MAGMA. 2010;23(4):243–9.

    PubMed  Article  Google Scholar 

  30. 30.

    Hsiao A, Alley MT, Massaband P, Herfkens RJ, Chan FP, Vasanawala SS. Improved cardiovascular flow quantification with time-resolved volumetric phase-contrast MRI. Pediatr Radiol. 2011;41(6):711–20.

    PubMed  Article  Google Scholar 

  31. 31.

    Hsiao A, Lustig M, Alley MT, Murphy M, Chan FP, Herfkens RJ, et al. Rapid pediatric cardiac assessment of flow and ventricular volume with compressed sensing parallel imaging volumetric cine phase-contrast MRI. AJR Am J Roentgenol. 2012;198(3):W250–9.

    PubMed  PubMed Central  Article  Google Scholar 

  32. 32.

    Hanneman K, Kino A, Cheng JY, Alley MT, Vasanawala SS. Assessment of the precision and reproducibility of ventricular volume, function, and mass measurements with ferumoxytol-enhanced 4D flow MRI. J Magn Reson Imaging. 2016;44(2):383–92.

    PubMed  PubMed Central  Article  Google Scholar 

  33. 33.

    Kamphuis VP, van der Palen RLF, de Koning PJH, Elbaz MSM, van der Geest RJ, de Roos A, et al. In-scan and scan-rescan assessment of LV in- and outflow volumes by 4D flow MRI versus 2D planimetry. J Magn Reson Imaging. 2018;47(2):511–22.

    PubMed  Article  Google Scholar 

  34. 34.

    Gabbour M, Schnell S, Jarvis K, Robinson JD, Markl M, Rigsby CK. 4-D flow magnetic resonance imaging: blood flow quantification compared to 2-D phase-contrast magnetic resonance imaging and Doppler echocardiography. Pediatr Radiol. 2015;45(6):804–13.

    PubMed  Article  Google Scholar 

  35. 35.

    Nordmeyer S, Riesenkampff E, Crelier G, Khasheei A, Schnackenburg B, Berger F, et al. Flow-sensitive four-dimensional cine magnetic resonance imaging for offline blood flow quantification in multiple vessels: a validation study. J Magn Reson Imaging. 2010;32(3):677–83.

    PubMed  Article  Google Scholar 

  36. 36.

    Kamphuis VP, Roest AAW, Ajmone Marsan N, van den Boogaard PJ, Kroft LJM, Aben JP, et al. Automated cardiac valve tracking for flow quantification with four-dimensional flow MRI. Radiology. 2019;290(1):70–8.

    PubMed  Article  Google Scholar 

  37. 37.

    Calkoen EE, Roest AA, Kroft LJ, van der Geest RJ, Jongbloed MR, van den Boogaard PJ, et al. Characterization and improved quantification of left ventricular inflow using streamline visualization with 4DFlow MRI in healthy controls and patients after atrioventricular septal defect correction. J Magn Reson Imaging. 2015;41(6):1512–20.

    PubMed  Article  Google Scholar 

  38. 38.

    Nordmeyer S, Riesenkampff E, Messroghli D, Kropf S, Nordmeyer J, Berger F, et al. Four-dimensional velocity-encoded magnetic resonance imaging improves blood flow quantification in patients with complex accelerated flow. J Magn Reson Imaging. 2013;37(1):208–16.

    PubMed  Article  Google Scholar 

  39. 39.

    Roes SD, Hammer S, van der Geest RJ, Marsan NA, Bax JJ, Lamb HJ, et al. Flow assessment through four heart valves simultaneously using 3-dimensional 3-directional velocity-encoded magnetic resonance imaging with retrospective valve tracking in healthy volunteers and patients with valvular regurgitation. Investig Radiol. 2009;44(10):669–75.

    Article  Google Scholar 

  40. 40.

    Feneis JF, Kyubwa E, Atianzar K, Cheng JY, Alley MT, Vasanawala SS, et al. 4D flow MRI quantification of mitral and tricuspid regurgitation: reproducibility and consistency relative to conventional MRI. J Magn Reson Imaging. 2018;48(4):1147–58.

    PubMed  Article  Google Scholar 

  41. 41.

    Vasanawala SS, Hanneman K, Alley MT, Hsiao A. Congenital heart disease assessment with 4D flow MRI. J Magn Reson Imaging. 2015;42(4):870–86.

    PubMed  Article  Google Scholar 

  42. 42.

    Cheng JY, Hanneman K, Zhang T, Alley MT, Lai P, Tamir JI, et al. Comprehensive motion-compensated highly accelerated 4D flow MRI with ferumoxytol enhancement for pediatric congenital heart disease. J Magn Reson Imaging. 2016;43(6):1355–68.

    PubMed  Article  Google Scholar 

  43. 43.

    Vasanawala SS, Alley MT, Hargreaves BA, Barth RA, Pauly JM, Lustig M. Improved pediatric MR imaging with compressed sensing. Radiology. 2010;256(2):607–16.

    PubMed  PubMed Central  Article  Google Scholar 

  44. 44.

    Winkelmann S, Schaeffter T, Koehler T, Eggers H, Doessel O. An optimal radial profile order based on the Golden ratio for time-resolved MRI. IEEE Trans Med Imaging. 2007;26(1):68–76.

    PubMed  Article  Google Scholar 

  45. 45.

    Uecker M, Lai P, Murphy MJ, Virtue P, Elad M, Pauly JM, et al. ESPIRiT--an eigenvalue approach to autocalibrating parallel MRI: where SENSE meets GRAPPA. Magn Reson Med. 2014;71(3):990–1001.

    PubMed  PubMed Central  Article  Google Scholar 

  46. 46.

    Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1(8476):307–10.

    CAS  PubMed  Article  Google Scholar 

  47. 47.

    Altman DG, Bland JM. Measurement in medicine: the analysis of method comparison studies. J Royal Statistical Society Series D (The Statistician). 1983;32(3):307–17.

    Google Scholar 

  48. 48.

    Bartlett JW, Frost C. Reliability, repeatability and reproducibility: analysis of measurement errors in continuous variables. Ultrasound Obstet Gynecol. 2008;31(4):466–75.

    CAS  PubMed  Article  Google Scholar 

  49. 49.

    Shrout PE, Fleiss JL. Intraclass correlations: uses in assessing rater reliability. Psychol Bull. 1979;86(2):420–8.

    CAS  Article  Google Scholar 

  50. 50.

    She HL, Roest AA, Calkoen EE, van den Boogaard PJ, van der Geest RJ, Hazekamp MG, et al. Comparative evaluation of flow quantification across the atrioventricular valve in patients with functional univentricular heart after Fontan's surgery and healthy controls: measurement by 4D flow magnetic resonance imaging and streamline visualization. Congenit Heart Dis. 2017;12(1):40–8.

    PubMed  Article  Google Scholar 

  51. 51.

    Karamitsos TD, Hudsmith LE, Selvanayagam JB, Neubauer S, Francis JM. Operator induced variability in left ventricular measurements with cardiovascular magnetic resonance is improved after training. J Cardiovasc Magn Reson. 2007;9(5):777–83.

    PubMed  Article  Google Scholar 

  52. 52.

    Westenberg JJ, Danilouchkine MG, Doornbos J, Bax JJ, van der Geest RJ, Labadie G, et al. Accurate and reproducible mitral valvular blood flow measurement with three-directional velocity-encoded magnetic resonance imaging. J Cardiovasc Magn Reson. 2004;6(4):767–76.

    PubMed  Article  Google Scholar 

  53. 53.

    Thavendiranathan P, Phelan D, Thomas JD, Flamm SD, Marwick TH. Quantitative assessment of mitral regurgitation: validation of new methods. J Am Coll Cardiol. 2012;60(16):1470–83.

    PubMed  Article  Google Scholar 

  54. 54.

    Tariq U, Hsiao A, Alley M, Zhang T, Lustig M, Vasanawala SS. Venous and arterial flow quantification are equally accurate and precise with parallel imaging compressed sensing 4D phase contrast MRI. J Magn Reson Imaging. 2013;37(6):1419–26.

    PubMed  Article  Google Scholar 

  55. 55.

    Ramalho J, Semelka RC, Ramalho M, Nunes RH, AlObaidy M, Castillo M. Gadolinium-based contrast agent accumulation and toxicity: an update. AJNR Am J Neuroradiol. 2016;37(7):1192–8.

    CAS  PubMed  Article  Google Scholar 

  56. 56.

    Bailie GR. Comparison of rates of reported adverse events associated with i.v. iron products in the United States. Am J Health Syst Pharm. 2012;69(4):310–20.

    CAS  PubMed  Article  Google Scholar 

  57. 57.

    Thavendiranathan P, Phelan D, Collier P, Thomas JD, Flamm SD, Marwick TH. Quantitative assessment of mitral regurgitation: how best to do it. JACC Cardiovasc Imaging. 2012;5(11):1161–75.

    PubMed  Article  Google Scholar 

Download references


Not applicable.



Author information




KJ designed the study, collected data, analyzed data, and wrote the manuscript. SM contributed to study design and data collection, assisted in data analysis, and provided major edits to the manuscript. SV contributed to conceptualization of project and the manuscript. FC, JG, MA, and JC edited the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Kimberley Jacobs.

Ethics declarations

Ethics approval and consent to participate

The Stanford University IRB approved this study and deemed that no informed consent was required.

Consent for publication

Not applicable.

Competing interests

KJ, FC, JG, SM: none. JC: research support from GE Healthcare and is a consultant for HeartVista, Inc. MA: ownership interest in Arterys and research support from GE Healthcare. SV: ownership interest in Arterys and has research support from GE Healthcare.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Additional file 1.

4DF CMR on Arterys of the AIMtrack method in a patient with tricuspid regurgitation.

Additional file 2.

4DF CMR on Arterys of the JET method in a patient with mitral regurgitation.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Jacobs, K., Rigdon, J., Chan, F. et al. Direct measurement of atrioventricular valve regurgitant jets using 4D flow cardiovascular magnetic resonance is accurate and reliable for children with congenital heart disease: a retrospective cohort study. J Cardiovasc Magn Reson 22, 33 (2020).

Download citation


  • 4DF CMR
  • 4D flow
  • Atrioventricular valve regurgitation
  • Direct measurement of regurgitant jet
  • Pediatric CHD
  • MRI